Product
Group CYS
Aliases
Cysteamine 5%
1 clinical trial
1 indication
Indication
MelasmaClinical trial
Randomized Controlled Investigator Blinded Comparative Study of the Efficacy and Tolerability of Test Product Versus Cysteamine 5% in the Treatment of Facial Epidermal Melasma Over 4 MonthsStatus: Recruiting, Estimated PCD: 2024-06-01